Thomson Reuters to Host tranSMART Community Meeting During BIO-IT World Conference
Published: Apr 04, 2013
This meeting will bring together key stakeholders from universities, non-profit research organizations, pharmaceutical and biotechnology companies, and vendors to discuss the future of translational research and to help speed promising discoveries from the laboratory to the clinic. It will also provide attendees with an overview of the tranSMART open-source, community-driven platform.
Presentations include an overview of the tranSMART Foundation (community home); a roadmap outlining tranSMART as the preferred data sharing and analytics platform for translational biomedical research; major initiatives and active projects including eTRIKS and TraIT; and the development of a partner network offering content and data curation, platform provisioning and implementation services.
This meeting is open to all interested parties but space is limited. Reservations for a space can be made online. Attendees will be welcomed on a first come, first served basis.
“The tranSMART community meeting in Boston is a great opportunity for interested parties to come together to learn the latest about our activity to date, “ said Dr. Brian Athey, co-chief executive officer of the tranSMART Foundation and chair of the Department of Computational Medicine and Bioinformatics at the University of Michigan Medical. “We continue to make steady progress in our efforts and are encouraged by the opportunity to highlight recent developments and future plans for tranSMART and to continue to grow our open source community. Many thanks to Thomson Reuters for supporting our international efforts.”
Dr. Michael Braxenthaler, co-chief executive officer of the tranSMART Foundation and Chairman of the Pistoia Alliance, added, “We are very happy to have Thomson Reuters involved in tranSMART and are looking forward to hosting the meeting with them and generating more interest in the community.”
“Our staff has been involved in providing implementation, development and deep curation expertise for relevant biological data for tranSMART since the inception of its platform,” said Joe Donahue, senior vice president at Thomson Reuters. “We are pleased to continue to support tranSMART, together with the tranSMART Foundation and the Pistoia Alliance, and the organizations that wish to implement it.”
For more information about the tranSMART professional solutions available from Thomson Reuters, please visit: http://thomsonreuters.com/content/science/pdf/ls/LS-201210-SCI-TRS-TranSMART-Brochure.pdf. tranSMART Foundation
The tranSMART FOUNDATION is a global non-profit organization devoted to realizing the promise of translational biomedical research through development of the tranSMART knowledge management platform. The mission of the tranSMART Foundation is to enable effective sharing, integration, standardization and analysis of heterogeneous data from collaborative translational research by mobilizing the tranSMART open-source and open-data community. The Pistoia Alliance and the University of Michigan are Co-founding members of the tranSMART Foundation. For more information, go to www.transmartfoundation.org/.
Since 2009, the Pistoia Alliance (www.pistoiaalliance.org) has worked to lower barriers to innovation by improving the interoperability of R&D business processes. Alliance members include over 70 life science companies, vendors, and content providers.
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minn., Thomson Reuters employs approximately 60,000 people and operates in over 100 countries. Thomson Reuters shares are listed on the Toronto and New York Stock Exchanges. For more information, go to www.thomsonreuters.com.
+1 215 823 1894